NCT06663137
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Relmada Site Raanana, Israel
Clinical trial condition
Non Muscle Invasive Bladder Cancer
Explore clinical trials studying Non Muscle Invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.
23 public trials
7 recruiting studies
Non Muscle Invasive Bladder Cancer trial results
NCT06972615
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- BLATAM CABA, Argentina
NCT07602010
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- Oslo University Hospital Oslo, Norway
NCT07283835
- Conditions
- Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +15 more
- Locations
-
- Peking University First Hospital (First Clinical Medical School of Peking University) Beijing, Beijing Municipality, China
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Fujian Cancer Hospital Fuzhou, Fujian, China
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
- Conditions
- Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029 Nanjing, Jiangsu, China
NCT06287541
- Conditions
- Carcinoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fanconi Syndrome, +18 more
- Locations
-
- The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
NCT06167356
- Conditions
- Bladder Cancer, Bladder Cancer Recurrent, Bladder Cancer Stage I, With Cancer in Situ, +22 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, MI, Italy
Not yet recruiting
Toripalimab Combined With Intravesical Gemcitabine as Adjuvant Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer After TURBT
NCT07808216
- Conditions
- Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
Not specified
Not yet recruiting
Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?
NCT07625527
- Conditions
- Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +14 more
- Locations
-
- The Second Hospital of Tianjin Medical University Tianjin, China
- General Hospital of Tianjin Medical University Tianjin, China
- Tianjin Hospital Tianjin, China
- Xingtai People's Hospital Xingtai, China
Not yet recruiting
Hyperthermic Intravesical Chemotherapy (HIVEC) in BCG-Non-Responsive High-Grade NMIBC Patients
NCT07231809
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma in Situ of Bladder, +16 more
- Locations
-
- P.O. "Santa Maria delle Grazie" - ASL Napoli 2 Nord Pozzuoli, Italy